Total Funding
38
5
Total FundingVenture - Series Unknown raised
Growth Score 38 in past quarter
-2 pts
Heat Score 5 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
852256
Theron Pharmaceuticals is a biotechnology company that develops therapeutic products for the treatment of chronic respiratory diseases.
- James Larrick: Chairman
- Allan Kramer: Director
About the Company
Theron Pharmaceuticals is a biotechnology company that develops long-acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. Its TRN-157 is a preclinical development program that focuses on the treatment of chronic obstructive pulmonary disease and severe asthma.
The company was founded in 2008 and is
based in Sunnyvale, California.
